Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
暂无分享,去创建一个
Samantha M. Carlisle | D. Standaert | E. Lefkowitz | A. West | E. Benveniste | Zhaoqi Yan | Richard E. Kennedy | A. Harms | T. Yacoubian | R. Hendrickson | H. Qin | Jordana Muwanguzi | S. Carlisle
[1] E. Hirsch,et al. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.
[2] Amit A. Patel,et al. Inherited and Environmental Factors Influence Human Monocyte Heterogeneity , 2019, Front. Immunol..
[3] Han-Joon Kim,et al. Peripheral Blood Inflammatory Cytokines in Idiopathic REM Sleep Behavior Disorder , 2019, Movement disorders : official journal of the Movement Disorder Society.
[4] Alan J. Thomas,et al. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease , 2019, International journal of geriatric psychiatry.
[5] Wei Yang,et al. Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production. , 2019, JCI insight.
[6] G. Casimir,et al. Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases , 2019, Front. Immunol..
[7] D. Standaert,et al. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease , 2018, Journal of Neuroinflammation.
[8] Wei Yang,et al. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1 , 2018, The Journal of Immunology.
[9] D. Standaert,et al. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease , 2018, Experimental Neurology.
[10] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[11] Wei Yang,et al. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation , 2017, The Journal of Immunology.
[12] M. Colonna,et al. Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.
[13] Marco Prinz,et al. The role of peripheral immune cells in the CNS in steady state and disease , 2017, Nature Neuroscience.
[14] Andreas W. Schreiber,et al. BAM-matcher: a tool for rapid NGS sample matching , 2016, Bioinform..
[15] D. Standaert,et al. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration , 2016, The Journal of Neuroscience.
[16] R. Barker,et al. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD) , 2016, Movement disorders : official journal of the Movement Disorder Society.
[17] A. West,et al. M1 and M2 immune activation in Parkinson’s Disease: Foe and ally? , 2015, Neuroscience.
[18] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[19] J. Kassubek,et al. Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients , 2014, Acta Neuropathologica.
[20] Daphne Koller,et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.
[21] Tom C. Freeman,et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.
[22] J. Langston,et al. Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease , 2013, PloS one.
[23] Robert Gentleman,et al. Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..
[24] D. Standaert,et al. MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration , 2013, The Journal of Neuroscience.
[25] Steffen Jung,et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. , 2013, Immunity.
[26] T. Gasser,et al. Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[27] Jie-zhong Yu,et al. Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil , 2013, PloS one.
[28] J. Meza,et al. CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.
[29] W. Oertel,et al. Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[30] Steffen Jung,et al. Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.
[31] E. Hirsch,et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.
[32] M. Frosch,et al. Effects of gender on nigral gene expression and parkinson disease , 2007, Neurobiology of Disease.
[33] Bastiaan R Bloem,et al. Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[34] K. H. Albrecht,et al. Supplemental Experimental Procedures cRNA Probe and Radioactive In Situ Hybridization , 2022 .
[35] D. Schaid,et al. Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.
[36] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[37] Zachary D. Wallen,et al. Innate and adaptive immune responses in Parkinson's disease. , 2020, Progress in brain research.
[38] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[39] T. Nagatsu,et al. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. , 1996, Neuroscience letters.